Phibro Animal Health Corporation (PAHC)
Return on equity (ROE)
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 2,416 | 13,162 | 14,799 | 20,735 | 32,606 | 28,595 | 36,242 | 46,497 | 49,175 | 58,809 | 53,281 | 48,617 | 54,385 | 42,906 | 44,246 | 43,339 | 33,552 | 36,712 | 38,060 | 40,914 |
Total stockholders’ equity | US$ in thousands | 256,641 | 270,094 | 270,803 | 273,069 | 282,509 | 272,328 | 268,370 | 262,756 | 262,442 | 266,945 | 239,294 | 233,305 | 238,529 | 215,921 | 213,322 | 192,412 | 188,204 | 195,345 | 217,415 | 206,694 |
ROE | 0.94% | 4.87% | 5.46% | 7.59% | 11.54% | 10.50% | 13.50% | 17.70% | 18.74% | 22.03% | 22.27% | 20.84% | 22.80% | 19.87% | 20.74% | 22.52% | 17.83% | 18.79% | 17.51% | 19.79% |
June 30, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $2,416K ÷ $256,641K
= 0.94%
The Return on Equity (ROE) of Phibro Animal Health Corporation has exhibited fluctuations over the past few quarters. The company's ROE has ranged from a low of 0.94% in June 2024 to a high of 22.80% in September 2022.
Overall, Phibro Animal Health Corporation's ROE shows variability, with some periods of stronger performance compared to others. The ROE has generally been on an upward trend from December 2019 to September 2022, with peak levels reached in the latter part of this period. However, there has been a slight decline in ROE in more recent quarters.
Investors and stakeholders may want to closely monitor the company's ROE trend to assess its profitability and efficiency in generating returns for shareholders. Fluctuations in ROE could be attributed to factors such as changes in the company's financial structure, profitability, asset utilization, and operating efficiency. Further analysis and context regarding the business operations and industry conditions may provide additional insights into understanding the drivers behind Phibro Animal Health Corporation's ROE performance.
Peer comparison
Jun 30, 2024